Skip to content

Atrium Therapeutics, Inc.

RNA Nasdaq SEC CIK 2093101

Follow Atrium Therapeutics Weekly email: filings, results, news

News

14 stories filed under Atrium Therapeutics

Markets

Thread · 4 stories

Wall Street Money Is Leaving Just As Atrium’s (RNA) Pipeline Turns Real

Markets 18 d ago

Maravai LifeSciences: The Post-COVID Reset Has Created An RNA Consumables Flywheel

Markets 22 d ago also on MRVI

STAT+: ARPA-H funds biotechs working on custom RNA therapies

Markets 22 d ago

Can Atrium Therapeutics (RNA)’s $15 Million Milestone From Bristol-Myers Squibb (BMY) Validate its RNA Platform?

Markets 27 d ago also on BMY

Deals

Thread · 2 stories · active today

RNAi drug specialist ADARx raises $446M IPO

Deals 1 h ago

Novartis RNA drug falls short in rare muscle disease study

Deals 16 d ago also on NVS

More coverage

Verici Dx (LSE:VRCI) lines up a transplant genetic test launch this week: could TranscripTx widen its reach?

Tech 13 h ago

AstraZeneca, Ionis data spark debate about RNA drugs’ impact on deadly heart disease

Markets 27 d ago also on AZN

Pinion Immunotherapeutics Publishes Preclinical Data Supporting Clinical-Ready RNA Immunotherapy for HPV-16 Cervical Precancer

Markets 27 d ago

Circio Holding ASA (0RIS) to Release H1 2026 Financial Results and Host Live circVec R&D Webcast on September 1

Markets 30 d ago also on ASA

ProQR Therapeutics: Buy For Axiomer RNA Tech Validation And Other Catalysts

Markets 34 d ago

Wave Life Sciences: An Fairly Valued RNA Opportunity

Markets 43 d ago also on WVE

Angola Works to Resolve Fuel Crisis Tied to Subsidies, RNA Says

Markets 49 d ago

Circio Holding ASA (0RIS) to Deliver Oral Presentation on circVec Platform at ESGCT 2026 in Hamburg

Markets 49 d ago also on ASA

Profile

Headquarters: SAN DIEGO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 14 stories clustered from the RSS aggregator